Document ID: chunk:federal_register_of_legislation:F2019L00230:reg:8:p3
Version: federal_register_of_legislation:F2019L00230
Segment Type: reg
Provision Reference: reg 8 (pt 3/3)
Character Range: 9501–10186

of at least seven days before the clinical worsening of chronic insomnia disorder, where:
             (a)          the involved drug is capable of producing a prominent and severe disturbance in sleep; and
             (b)          the drug is associated in the individual with the worsening of insomnia symptoms during drug therapy; and
             (c)          the last dose was received within the 30 days before the clinical worsening of chronic insomnia disorder;
(25)      being treated with mefloquine within the two months before the clinical worsening of chronic insomnia disorder;
(26)      inability to obtain appropriate clinical management for chronic insomnia disorder.